{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:46:07Z","timestamp":1792176367810,"version":"4.4.0"},"reference-count":71,"publisher":"BMJ","issue":"1","funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["G1002033"],"award-info":[{"award-number":["G1002033"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Arch Dis Child Fetal Neonatal Ed"],"accepted":{"date-parts":[[2021,1,14]]},"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:p>Illicit use of opioids is a global health crisis with major implications for women and children. Strategies for managing opioid use disorder (OUD) in pregnancy have been tested over the past 40 years, but studies have focused on maternal and pregnancy outcomes, with less attention given to long-term follow-up of exposed children. Here, we provide a narrative review of recent advances in the assessment and management of neonatal opioid withdrawal syndrome (NOWS), and we summarise evidence from multiple domains\u2014neuroimaging, electrophysiology, visual development and function, neurodevelopment, behaviour, cognition and education\u2014which suggests that prenatal opioid exposure modifies child development. Further studies are required to determine the optimal management of pregnant women with OUD and babies with NOWS. We identify knowledge gaps and suggest that future study designs should evaluate childhood outcomes, including infant brain development and long-term neurocognitive and visual function.<\/jats:p>","DOI":"10.1136\/archdischild-2020-320102","type":"journal-article","created":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T04:31:29Z","timestamp":1613622689000},"page":"98-104","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":22,"title":["Opioids and the developing brain: time to rethink perinatal care for infants of opioid-dependent mothers"],"prefix":"10.1136","volume":"107","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3904-8960","authenticated-orcid":false,"given":"James P","family":"Boardman","sequence":"first","affiliation":[{"name":"MRC Centre for Reproductive Health, The University of Edinburgh, Edinburgh, UK"},{"name":"Centre for Clinical Brain Sciences, The University of Edinburgh, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6154-5758","authenticated-orcid":false,"given":"Helen","family":"Mactier","sequence":"additional","affiliation":[{"name":"Neonatology, Princess Royal Maternity, Glasgow, UK"},{"name":"Princess Royal Maternity, University of Glasgow, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori A","family":"Devlin","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Louisville, Louisville, Kentucky, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,2,17]]},"reference":[{"key":"2025090501353167000_107.1.98.1","unstructured":"World Drug Report 2020 . Drug use and health consequences: United nations publication, sales No. E.20.XI.6: 2020."},{"key":"2025090501353167000_107.1.98.2","unstructured":"Office for National Statistics . Deaths related to drug poisoning in England and Wales: 2018 registrations. London, 2019."},{"key":"2025090501353167000_107.1.98.3","unstructured":"National Records of Scotland . Drug-Related deaths in Scotland on 2018. Edinburgh, 2019."},{"key":"2025090501353167000_107.1.98.4","unstructured":"Centers for Disease Control and Prevention . Analysis of the National vital statistics system multiple cause of death data. wide-ranging online data for epidemiologic research (wonder. Atlanta, GA, 2017."},{"key":"2025090501353167000_107.1.98.5","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6911a4"},{"key":"2025090501353167000_107.1.98.6","unstructured":"Center for Disease Prevention and Control, National Center for Health Statistics . Wide-Ranging online data for epidemiologic research (wonder. Atlanta, GA, 2020."},{"key":"2025090501353167000_107.1.98.7","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00127-017-1355-3","article-title":"Gender differences in the effects of childhood adversity on alcohol, drug, and polysubstance-related disorders","volume":"52","author":"Evans","year":"2017","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"2025090501353167000_107.1.98.8","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000002235"},{"key":"2025090501353167000_107.1.98.9","unstructured":"World Health Organization . Guidelines for the identification and management of substance use and substance use disorders in pregnancy. Geneva, 2014."},{"key":"2025090501353167000_107.1.98.10","unstructured":"Department of Health . Drug misuse and dependence: UK guidelines on clinical management. clinical guidelines on drug misuse and dependence update 2017 independent expert Working group. London, 2017."},{"key":"2025090501353167000_107.1.98.11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2006.01651.x"},{"key":"2025090501353167000_107.1.98.12","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002209.pub2"},{"key":"2025090501353167000_107.1.98.13","first-page":"CD006318","article-title":"Maintenance agonist treatments for opiate-dependent pregnant women","volume":"12","author":"Minozzi","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"2025090501353167000_107.1.98.14","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwu190"},{"key":"2025090501353167000_107.1.98.15","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1515\/nsad-2016-0023","article-title":"Pregnant substance-abusing women in involuntary treatment: attachment experiences with the unborn child","volume":"33","author":"Myra","year":"2016","journal-title":"Nordic Studies on Alcohol and Drugs"},{"key":"2025090501353167000_107.1.98.16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1600879"},{"key":"2025090501353167000_107.1.98.17","unstructured":"State Inpatient Databases . Healthcare cost and utilization project (HCUP): agency for healthcare research and quality (AHRQ, 2020."},{"key":"2025090501353167000_107.1.98.18","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2015-308948"},{"key":"2025090501353167000_107.1.98.19","first-page":"141","article-title":"Neonatal abstinence syndrome: assessment and management","volume":"2","author":"Finnegan","year":"1975","journal-title":"Addict Dis"},{"key":"2025090501353167000_107.1.98.20","doi-asserted-by":"publisher","DOI":"10.1177\/000992287501400613"},{"key":"2025090501353167000_107.1.98.21","doi-asserted-by":"publisher","DOI":"10.1097\/00004703-199804000-00005"},{"key":"2025090501353167000_107.1.98.22","doi-asserted-by":"publisher","DOI":"10.3109\/00952998108999125"},{"key":"2025090501353167000_107.1.98.23","first-page":"187","article-title":"A study of factors that influence the severity of neonatal narcotic withdrawal","volume":"2","author":"Ostrea","year":"1975","journal-title":"Addict Dis"},{"key":"2025090501353167000_107.1.98.24","doi-asserted-by":"crossref","first-page":"47","DOI":"10.5055\/jom.2009.0006","article-title":"The opioid-exposed newborn: assessment and pharmacologic management","volume":"5","author":"Jansson","year":"2009","journal-title":"J Opioid Manag"},{"key":"2025090501353167000_107.1.98.25","first-page":"19","article-title":"Assessment and treatment of abstinence in the infant of the drug-dependent mother","volume":"12","author":"Finnegan","year":"1975","journal-title":"Int J Clin Pharmacol Biopharm"},{"key":"2025090501353167000_107.1.98.26","doi-asserted-by":"publisher","DOI":"10.1186\/1940-0640-9-19"},{"key":"2025090501353167000_107.1.98.27","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1005359"},{"key":"2025090501353167000_107.1.98.28","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-016176"},{"key":"2025090501353167000_107.1.98.29","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1038\/s41372-020-0606-4","article-title":"Development of an abbreviated symptom score for the neonatal abstinence syndrome","volume":"40","author":"Chervoneva","year":"2020","journal-title":"J Perinatol"},{"key":"2025090501353167000_107.1.98.30","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.2275","article-title":"Association of a simplified Finnegan neonatal abstinence scoring tool with the need for pharmacologic treatment for neonatal abstinence syndrome","volume":"3","author":"Devlin","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2025090501353167000_107.1.98.31","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-3360","article-title":"An initiative to improve the quality of care of infants with neonatal abstinence syndrome","volume":"139","author":"Grossman","year":"2017","journal-title":"Pediatrics"},{"key":"2025090501353167000_107.1.98.32","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/s41372-018-0109-8","article-title":"Quality improvement initiative to improve inpatient outcomes for neonatal abstinence syndrome","volume":"38","author":"Wachman","year":"2018","journal-title":"J Perinatol"},{"key":"2025090501353167000_107.1.98.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcl.2018.12.006"},{"key":"2025090501353167000_107.1.98.34","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1001\/jamapediatrics.2017.5195","article-title":"Association of rooming-in with outcomes for neonatal abstinence syndrome: a systematic review and meta-analysis","volume":"172","author":"MacMillan","year":"2018","journal-title":"JAMA Pediatr"},{"key":"2025090501353167000_107.1.98.35","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2008.02073.x"},{"key":"2025090501353167000_107.1.98.36","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.siny.2019.01.001","article-title":"Breastmilk feeding for mothers and infants with opioid exposure: what is best?","volume":"24","author":"Bogen","year":"2019","journal-title":"Semin Fetal Neonatal Med"},{"key":"2025090501353167000_107.1.98.37","first-page":"997","article-title":"Buprenorphine for the neonatal abstinence syndrome","volume":"377","author":"Kraft","year":"2017","journal-title":"N Engl J Med"},{"key":"2025090501353167000_107.1.98.38","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S70585"},{"key":"2025090501353167000_107.1.98.39","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1001\/jamapediatrics.2018.5044","article-title":"Pharmacological treatments for neonatal abstinence syndrome: a systematic review and network meta-analysis","volume":"173","author":"Disher","year":"2019","journal-title":"JAMA Pediatr"},{"key":"2025090501353167000_107.1.98.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2015.07.001"},{"key":"2025090501353167000_107.1.98.41","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1600917"},{"key":"2025090501353167000_107.1.98.42","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2010.03120.x"},{"key":"2025090501353167000_107.1.98.43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2017.07.026"},{"key":"2025090501353167000_107.1.98.44","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/0165-3806(96)00045-4","article-title":"Postnatal methadone exposure Doe not prevent prenatal methadone-induced changes in striatal cholinergic neurons","volume":"95","author":"Robinson","year":"1996","journal-title":"Brain Res Dev Brain Res"},{"key":"2025090501353167000_107.1.98.45","doi-asserted-by":"publisher","DOI":"10.1159\/000365074"},{"key":"2025090501353167000_107.1.98.46","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2013.10.027"},{"key":"2025090501353167000_107.1.98.47","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/nan.12589","article-title":"Invited review: factors associated with atypical brain development in preterm infants: insights from magnetic resonance imaging","volume":"46","author":"Boardman","year":"2020","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2025090501353167000_107.1.98.48","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.nicl.2017.12.033","article-title":"Prenatal methadone exposure is associated with altered neonatal brain development","volume":"18","author":"Monnelly","year":"2018","journal-title":"Neuroimage Clin"},{"key":"2025090501353167000_107.1.98.49","doi-asserted-by":"publisher","DOI":"10.1111\/add.12400"},{"key":"2025090501353167000_107.1.98.50","doi-asserted-by":"crossref","DOI":"10.1001\/jamapediatrics.2020.1622","article-title":"Associations of maternal prenatal drug abuse with measures of newborn brain structure, tissue organization, and metabolite concentrations","volume":"174","author":"Peterson","year":"2020","journal-title":"JAMA Pediatr"},{"key":"2025090501353167000_107.1.98.51","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2012.04.008"},{"key":"2025090501353167000_107.1.98.52","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ntt.2010.09.003","article-title":"Fetal neurobehavioral effects of exposure to methadone or buprenorphine","volume":"33","author":"Jansson","year":"2011","journal-title":"Neurotoxicol Teratol"},{"key":"2025090501353167000_107.1.98.53","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2009.181701"},{"key":"2025090501353167000_107.1.98.54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14767058.2019.1579190","article-title":"Amplitude-integrated EEG use in neonatal abstinence syndrome: a pilot study","volume":"33","author":"Limjoco","year":"2020","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2025090501353167000_107.1.98.55","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2012-2113"},{"key":"2025090501353167000_107.1.98.56","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2013-303967"},{"key":"2025090501353167000_107.1.98.57","unstructured":"Hamilton R , Butler L , Chow A . Long-Term visual outcomes of children born to opioid-dependent, methadone-maintained mothers suggest a foetal opioid syndrome. 58th Annual Symposium of the International Society of Clinical Electrophysiology of Vision 2020."},{"key":"2025090501353167000_107.1.98.58","doi-asserted-by":"publisher","DOI":"10.1016\/j.ntt.2009.09.001"},{"key":"2025090501353167000_107.1.98.59","doi-asserted-by":"publisher","DOI":"10.1080\/08035250310009329"},{"key":"2025090501353167000_107.1.98.60","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2009.169284"},{"key":"2025090501353167000_107.1.98.61","doi-asserted-by":"publisher","DOI":"10.3928\/01913913-20110308-01"},{"key":"2025090501353167000_107.1.98.62","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2013.02.004"},{"key":"2025090501353167000_107.1.98.63","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2013-304158"},{"key":"2025090501353167000_107.1.98.64","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/aos.12627","article-title":"Smoking during pregnancy and vision difficulties in children: a systematic review","volume":"93","author":"Fernandes","year":"2015","journal-title":"Acta Ophthalmol"},{"key":"2025090501353167000_107.1.98.65","doi-asserted-by":"publisher","DOI":"10.1016\/j.acap.2019.11.005"},{"key":"2025090501353167000_107.1.98.66","doi-asserted-by":"crossref","DOI":"10.1111\/dmcn.14117","article-title":"Childhood neurodevelopment after prescription of maintenance methadone for opioid dependency in pregnancy: a systematic review and meta-analysis","volume":"61","author":"Monnelly","year":"2019","journal-title":"Dev Med Child Neurol"},{"key":"2025090501353167000_107.1.98.67","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/DBP.0000000000000711","article-title":"Health and neurodevelopment of children born to opioid-dependent mothers at school entry","volume":"41","author":"Lee","year":"2020","journal-title":"J Dev Behav Pediatr"},{"key":"2025090501353167000_107.1.98.68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0223685","article-title":"Educational achievement at age 9.5 years of children born to mothers maintained on methadone during pregnancy","volume":"14","author":"Lee","year":"2019","journal-title":"PLoS One"},{"key":"2025090501353167000_107.1.98.69","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-2651","article-title":"Neonatal abstinence syndrome and high school performance","volume":"139","author":"Oei","year":"2017","journal-title":"Pediatrics"},{"key":"2025090501353167000_107.1.98.70","doi-asserted-by":"publisher","DOI":"10.1080\/09297049.2015.1092509"},{"key":"2025090501353167000_107.1.98.71","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2018-316440"}],"container-title":["Archives of Disease in Childhood - Fetal and Neonatal Edition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/archdischild-2020-320102","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T08:35:58Z","timestamp":1757061358000},"score":1,"resource":{"primary":{"URL":"https:\/\/fn.bmj.com\/lookup\/doi\/10.1136\/archdischild-2020-320102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,17]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12,15]]},"published-print":{"date-parts":[[2022,1]]}},"alternative-id":["10.1136\/archdischild-2020-320102"],"URL":"https:\/\/doi.org\/10.1136\/archdischild-2020-320102","relation":{},"ISSN":["1359-2998","1468-2052"],"issn-type":[{"value":"1359-2998","type":"print"},{"value":"1468-2052","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,17]]}}}